Clinical Trial Update: Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

View source ↗

Summary

Pfizer-sponsored observational study to assess maternal, fetal, and infant outcomes following exposure to rimegepant in pregnant individuals; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Status: RECRUITING